BioSpace News Archive

Technological improvements in anesthesiology are well known. These techniques are primarily used to enhance the patient’s safety.

Consumer genetics testing and medical diagnostics pioneer DnaNudge announces that it has successfully completed a $60 million Series A investment round led by investment company Ventura Capital.

A buildup of coronavirus in the lungs is likely behind the steep mortality rates seen in the pandemic, a new study finds.

Pharmaxis announced that its novel topical drug treatment for scarring has delivered positive Phase 1 clinical trial results and will now advance to the next stage of development in patients.

ANI Pharmaceuticals, Inc. announced that the Company’s supplemental New Drug Application for Purified Cortrophin® Gel has been accepted by the U.S. Food and Drug Administration for review.

McMaster University researchers using MediPharm Labs’ CBD50 formula and a CBD:THC 10:2 formulation, which has the same cannabinoid ratio as MediPharm Labs’ CBD25:, have received a No Objection Letter from Health Canada to begin recruiting human subjects for a placebo-controlled trial using cannabis- oil for treatment of insomnia in major depressive disorder.

Electroencephalogram (EEG) refers to neurophysiologic estimation of the electrical activity of the brain recorded and analyzed with the help of electrodes placed on the scalp or, in special cases, is inserted subdurally or in the cerebral cortex.

Fact.MR – A Market Research and Competitive Intelligence Provider: As per the latest study by Fact.MR, the combined immune deficiency market will grow at a healthy rate through 2021 and years ahead.

Fact.MR – A Market Research and Competitive Intelligence Provider: As per Fact.MR, the global market for inhalational anaesthesia drugs is anticipated to grow at a healthy CAGR over the assessment period 2021.

Verona Pharma plc, a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that David Zaccardelli, Pharm. D., President and Chief Executive Officer, will present a company overview at the H.C. Wainwright 23rd Annual Global Investment Conference.